|1.||Augustijns, Patrick: 1 article (01/2014)|
|2.||Chatterjee, Sagnik: 1 article (01/2014)|
|3.||Annaert, Pieter: 1 article (01/2014)|
|4.||Richert, Lysiane: 1 article (01/2014)|
|5.||Belov, B S: 1 article (01/2013)|
|6.||Gureev, V V: 1 article (03/2009)|
|7.||Chernomortseva, E S: 1 article (03/2009)|
|8.||Artiushkova, E B: 1 article (03/2009)|
|9.||Pokrovskiĭ, M V: 1 article (03/2009)|
|10.||Pokrovskaia, T G: 1 article (03/2009)|
06/01/1982 - "Moreover, midecamycin acetate showed high therapeutic efficacy for subcutaneous infections due to Staph. "
06/01/1982 - "In vivo therapeutic experiments in experimental infections in mice, midecamycin acetate was shown to be much superior to other drugs tested in the therapeutic efficacy against intraperitoneal infections caused by Staph. "
10/01/1986 - "[Midecamycin acetate-susceptibility of clinical isolates from dental and oral surgical infections]."
08/01/1985 - "Midecamycin in the treatment of otorhinolaryngological infections."
07/01/1979 - "On the basis of these results, the use of Midecamycin is therefore recommended in the treatment of Gram-positive infections in the dental field."
04/01/1979 - "Taking into consideration the antimicrobial activity of midecamycin against Mycoplasma pneumoniae, serum concentration and side effects of midecamycin, this antibiotic is expected to be effective in the treatment of Mycoplasma pneumoniae pneumonia."
04/01/1979 - "The clinical efficacy of a macrolide antibiotic, midecamycin, was studied in 12 adult cases with Mycoplasma pneumoniae pneumonia. "
04/01/1979 - "[Therapeutic effect of midecamycin on Mycoplasma pneumoniae pneumonia in adults (author's transl)]."
08/01/1977 - "4) In all the 3 cases of pneumonia due to Mycoplasma, response to midecamycin was assessed as excellent. "
05/01/1989 - "The clinical efficacy and safety of Roxithromycin (RU) were compared with those of Midecamycin acetate (MOM) in patients with pneumonia in a double blind study. "
08/01/1977 - "3) In the treatment of a total of 19 acute cases, consisting of 9 cases of tonsillitis, 7 cases of lacunar tonsillitis and 3 cases of bronchitis, midecamycin was found effective in 79% of the cases. "
11/01/1982 - "[Comparative study of the effectiveness of 9,3"-di-O-acetyl midecamycin (MOM) and josamycin (JM) against acute tonsillitis by double blind method]."
01/01/2013 - "The agents of choice for the treatment of acute forms of BHSA (tonsillitis and pharyngitis) include penicillins (amoxicillin, benzathine-penicillin, phenoxymethyl penicillin) and cephalosporins of the first generation (cephadroxyl) as well as macrolids (spiramycin, azithromycin, roxithromycin, midecamycin, josamycin) for the patients who do not tolerate beta-lactam antibiotics. "
|3.||staphylococcal enterotoxin B
|5.||Anti-Bacterial Agents (Antibiotics)
|6.||Josamycin (EN 141)